Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: A real‐world study in two Italian cohorts
Year: 2021
Type: review
Study design: Observational Study
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14361
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: diabetes mellitus, GLP-1 receptor agonists, SGLT2 inhibitors, antidiabetic drugs, cardiovascular events, mortality, ischemic stroke, cerebrovascular disease, peripheral vascular disease, lower limb amputation, drug safety, real-world evidence, propensity score matching, Lombardy, Apulia, Italy, comparative effectiveness, first-time users, type 2 diabetes
Open Access status: closed
OpenAlex ID: W3130013319
